DOCSLIB.ORG

Hypothyroidism (1 of 7)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hypothyroidism (1 of 7) Hypothyroidism (1 of 7) 1 Patient presents w/ signs & symptoms suggestive of hypothyroidism 2 DIAGNOSIS Evaluate thyroid stimulating hormone (TSH) & thyroxine (FT4) levels High TSH & High TSH Low/normal normal FT4 & low FT4 TSH & low FT4 3 4 5 SUBCLINICAL/MILD PRIMARY CENTRAL HYPOTHYROIDISM HYPOTHYROIDISM HYPOTHYROIDISM A Pharmacological 5 therapy THERAPY • EVALUATION DECISION Levothyroxine See next page A FOLLOWUP Pharmacological therapy Follow-up exams • Levothyroxine • Every 6-8 weeks initially to monitor patient’s response to MIMSthe dose of Levothyroxine until TSH is normalized • en every FOLLOWUP 6-12 months Follow-up exams • Every 6-8 weeks initially to monitor patient’s response to the dose of Levothyroxine to maintain FT4 above the median value of © normal range • en every 12 months Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B1 © MIMS 2020 Hypothyroidism (2 of 7) THERAPY DECISION FOR SUBCLINICAL/MILD HYPOTHYROIDISM HYPOTHYROIDISM yroid antibody present? Yes No DETERMINE TSH LEVEL TSH TSH ≥10 mU/L <10 mU/L 3 A Pharmacological therapy Presence of goiter, Yes • Low-dose Levothyroxine high total or LDL-C level, other symptoms? No FOLLOWUP Follow-up exams • Every 4-8 weeks initially to monitor patient’s response to the dose of Levothyroxine ANNUAL until TSH is normalized THYROID • en every 12 months MIMSEXAM © Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B2 © MIMS 2020 Hypothyroidism (3 of 7) 1 HYPOTHYROIDISM • yroid hormone defi ciency due to underactive thyroid that may be secondary to hypothalamic-pituitary disease or primary thyroid disease Signs & Symptoms • Variable signs & symptoms but typical symptoms are fatigue, weight gain, cold intolerance, constipation & dry skin • HYPOTHYROIDISM Neurological - Weakness - Depression - Poor memory - Delayed relaxation of deep tendon refl exes • Head & neck - Periorbital puffi ness - Hair loss/alopecia - Voice change; hoarseness - Slow speech • Gastrointestinal - Constipation • Cardiovascular - Bradycardia - Hyperlipidemia - Pericardial eff usion • Others - Menorrhagia - Myxedema (non-pitting edema) - Pallor - Goiter - Myalgia - Anemia - Galactorrhea Special Population w/ Higher Risk of Developing Hypothyroidism • Postpartum women • Infertile individuals • Individuals w/ a family history of autoimmune thyroid disorders • Patients w/ previous head & neck or thyroid irradiation • Other autoimmune endocrine conditions - Type 1 diabetes mellitus (DM), adrenal insuffi ciency (AI), ovarian failure • Other non-endocrine autoimmune disorders - Celiac disease, vitiligo, pernicious anemia, Sjogren’s syndrome, multiple sclerosis • Down’s & Turner’s syndrome 2 DIAGNOSIS Lab Tests MIMS Confi rmation & Types of Hypothyroidism • Measure serum thyroid stimulating hormone (TSH): Most sensitive test for detecting hypothyroidism • Confi rm w/ measurement of serum thyroxine (FT4) • Primary hypothyroidism: High TSH & low FT4 • Central hypothyroidism: Low/normal TSH & low FT4 • Subclinical hypothyroidism: High TSH & normal FT4 Other Tests • Lipid profi le • yroid autoantibodies - Antithyroid© peroxidase, antithyroglobulin autoantibodies • yroid scan, ultrasonography (may do both) • Neuroradiologic studies [magnetic resonance imaging (MRI) or computed tomography (CT)] - Recommended in patients w/ biochemical evidence of central hypothyroidism to assess the hypothalamic- pituitary region B3 © MIMS 2020 Hypothyroidism (4 of 7) 3 SUBCLINICAL/MILD HYPOTHYROIDISM • Refers to the state of slightly increased serum TSH w/ normal serum FT4 in patients who are usually asymptomatic Other Causes of Elevated TSH that Should be Excluded • Recent Levothyroxine dose adjustment wherein a steady state is not achieved • Transient increase in TSH during recovery from severe illness or destructive thyroiditis • Untreated primary adrenal insuffi ciency HYPOTHYROIDISM • Administration of recombinant human TSH • Presence of heterophilic antibodies against mouse proteins • Temporary increase in TSH due to calorie intake restriction Determination of Treatment for Subclinical Hypothyroidism: Further Evaluation • yroid antibodies detection (if positive, for treatment); if negative (TSH >10 mU/L, for treatment) • Physical exam • Lipid profi le • yroid ultrasound Risk Assessment • Higher risk of progression to overt hypothyroidism if TSH >10 mU/L, presence of thyroid antibodies, goiter, hyperlipidemia, pregnancy, ovulatory dysfunction w/ infertility - Treatment is recommended in higher risk patients - If patient is not at high risk, perform annual thyroid exam 4 PRIMARY HYPOTHYROIDISM Etiologies Autoimmune yroiditis (Hashimoto’s Disease) • Most common cause • Diagnosis - yroid antibodies [anti-thyroid peroxidase (TPO)- in 95% or antithyroglobulin (TG) detection in 60%] - Careful history of radiation exposure, radioactive iodine therapy, neck surgery, recent viral infection, medi- cations, pregnancy, change in diet - Presence of thyroid antibodies & absence of any of the above history confi rms diagnosis of Hashimoto’s thyroiditis Other Causes • Congenital: Endemic iodine defi ciency (Athyreosis, dyshormonogenesis), thyroid hormone resistance, TSH-receptor defect • Acquired: Iodine defi ciency, iatrogenic (post-thyroidectomy, thyroid irradiation, medications, radioactive iodine therapy) • Transient: Subacute thyroiditis (de Quervain’s), lymphocytic thyroiditis (silent, postpartum & painless thyroid- itis), neonatal hypothyroidism 5 CENTRAL HYPOTHYROIDISM Evaluation MIMS • orough exam of the function of the hypothalamic-pituitary axis • Determine adrenal status, if adrenal insuffi cient: - yroxine administration may increase metabolism & precipitate an adrenal crisis - Glucocorticoid should be replaced prior to thyroxine administration to avoid adrenal crisis Etiologies • Divided into secondary hypothyroidism (defect is in the pituitary gland) & tertiary hypothyroidism (defect is in the hypothalamus) • Occurs due to failure of the hypothalamic-pituitary axis causing decreased TSH secretion or reduced TSH biological activity • Pituitary: ©Tumor, vascular insuffi ciency, empty sella syndrome, infi ltrating disease, infection, iatrogenic (surgery & radiotherapy) • Hypothalamic: Tumor, infection, vascular insuffi ciency, thyrotropin-releasing hormone (TRH) defi ciency, iatrogenic Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B4 © MIMS 2020 Hypothyroidism (5 of 7) LIFETHREATENING COMPLICATION MYXEDEMA COMA 1 Patient presents w/ signs & symptoms suggestive of myxedema coma HYPOTHYROIDISM ADMIT TO ICU CONFIRM DIAGNOSIS Non-pharmacological therapy • Close monitoring & supportive care - IV fl uids, gradual warming - Monitor CV function & for syndrome of inappropriate secretion of antidiuretic hormone (SIADH) - Ensure adequate ventilation - Treat underlying cause A Pharmacological therapy • Glucocorticoids - If central hypothyroidism cannot be ruled out • Levothyroxine IV or oral via NGT &/or Liothyronine IV 1 MYXEDEMA COMA • Correct diagnosis is imperative because critical illnesses are clinically similar to myxedema coma & can also present w/ altered thyroid function - If diagnosis is wrong, high doses of thyroid hormone is dangerous to the patient • A high suspicion of myxedema coma can be made in a poorly responsive patient w/ a thyroidectomy scar or history of radioiodine therapy or hypothyroidism - ere may also be antecedent symptoms of thyroid dysfunction followed by progressive lethargy, stupor & coma Signs & Symptoms • Severe hypothermia (<27°C) • Bradycardia • Respiratory failure & loss of consciousness • Hypercapnia • Hyponatremia • Long-standing hypothyroidism MIMS Precipitating Factors • Infection • CV event • History of thyroidectomy or radioiodine therapy • Exposure to cold Diagnostic Tests • Very low serum T4 concentration • High serum TSH concentration • Diagnostic scoring system for myxedema coma gives points for the degree of hypothermia, neurological eff ects, gastrointestinal© fi ndings, precipitating event, cardiovascular dysfunction, & metabolic disturbances - Score of ≥60 is highly suggestive of myxedema coma, while scores between 45 & 59 classify the patient at risk for myxedema coma Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B5 © MIMS 2020 Hypothyroidism (6 of 7) A PHARMACOLOGICAL THERAPY1 Levothyroxine • 1st-line agent for treatment of hypothyroidism • May be used to manage myxedema coma • Safe for use in pregnancy • Actions: HYPOTHYROIDISM - Used as a replacement therapy in hypothyroidism to substitute thyroid hormone - Long half-life (T½), slow onset, regular bioconversion which is appropriately regulated by the tissues to the biologically active compound T3 • Eff ects: Safe & predictable eff ects - Requires several weeks to achieve peak therapeutic eff ects w/ regular oral dosing • Due to diff erent bioavailability of the various preparations of Levothyroxine, patients are encouraged to use the same brand of Levothyroxine - If a change in brand is needed, the patient’s serum TSH should be retested every 6 weeks & dosage of Levothyroxine be re-titrated Liothyronine • Actions: - Short T½, rapid onset - Biologically active compound (no conversion is necessary) - Used as a replacement therapy in hypothyroidism to substitute thyroid hormone • Generally
Load more

Recommended publications
  • Endocrine Emergencies
    Endocrine Emergencies • Neuroendocrine response to Critical illness • Thyroid storm/Myxedema Coma • Adrenal Crisis/Sepsis • Hyper/Hypocalcemia • Hypoglycemia • Hyper and Hyponatremia • Pheochromocytoma crises CASE 76 year old man presents with urosepsis and is Admitted to MICU. He has chronic renal insufficiency. During his hospital course, he is intubated and treated With dopamine. Thyroid studies are performed for Inability to wean from ventilator. What labs do you want? Assessment of Thyroid Function • Hormone Levels: Total T4, Total T3 • Binding proteins: TBG, (T3*) Resin uptake • Free Hormone Levels: TSH, F T4, F T3, Free Thyroid Index, F T4 by Eq Dialysis • Radioactive Iodine uptake (RAIU); primarily for DDx of hyperthyroidism • Thyroid antibodies; TPO, Anti-Thyroglobulin, Thyroid stimulating immunoglobulins, Th receptor antibodies Labs: T4 2.4 ug/dl (5-12) T3U 40% (25-35) FTI 1.0 (1.2-4.2) FT4 0.6 (0.8-1.8) TSH 0.2 uU/ml (.4-5.0) Non-thyroidal illness • Hypothesis: NTI vs 2° Hypothyroidism –RT3 ↑ in NTI and ↓ in Hypothyroidism • Hypothesis: NTI vs Hyperthyroidism – TT3 ↓ in NTI and in ↑ Hyperthyroidism • 75 year old woman with history of hypothyroidism is found unresponsive in her home during a cold spell in houston. No heat in the home. • Exam: T° 95, BP 100/60, P 50, RR 8 • Periorbital edema, neck scar, no rub or gallop, distant heart sounds, crackles at bases, peripheral edema • ECG: Decreased voltage, runs of Torsade de pointes • Labs? Imaging? • CXR: cardiomegaly • Glucose 50 • Na+ 120, K+ 4, Cl 80, HCO3¯ 30 • BUN 30 Creat 1.4 • ABG: pH 7.25, PCO2 75, PO2 80 • CK 600 • Thyroid studies pending • Management: Manifestations of Myxedema Coma • Precipitated by infection, iatrogenic (surgery, sedation, diuretics) • Low thyroid studies • Hypothermia • Altered mental status • Hyponatremia • ↑pCO2 • ↑CK • ↑Catecholamines with ↑vascular resistance • Cardiac: low voltage, Pericardial effusion, impaired relaxation with ↓C.O.
    [Show full text]
  • Thyroid Emergencies
    REVIEW ARTICLE Thyroid emergencies Dorina Ylli1, Joanna Klubo ‑Gwiezdzinska2, Leonard Wartofsky3,4 1 Endocrinology Division, University of Medicine, Tirana, Albania 2 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States 3 Endocrinology Division, Department of Medicine, Georgetown University School of Medicine, Washington DC, United States 4 MedStar Health Research Institute, MedStar Washington Hospital Center, Washington DC, United states KEY WORDS ABSTRACT coma, critical care, Myxedema coma and thyroid storm are among the most common endocrine emergencies presenting to hypothermia, general hospitals. Myxedema coma represents the most extreme, life ‑threatening expression of severe hypothyroidism, hypothyroidism, with patients showing deteriorating mental status, hypothermia, and multiple organ thyrotoxicosis system abnormalities. It typically appears in patients with preexisting hypothyroidism via a common pathway of respiratory decompensation with carbon dioxide narcosis leading to coma. Without early and appropriate therapy, the outcome is often fatal. The diagnosis is based on history and physical find‑ ings at presentation and not on any objective thyroid laboratory test. Clinically based scoring systems have been proposed to aid in the diagnosis. While it is a relatively rare syndrome, the typical patient is an elderly woman (thyroid hypofunction being much more common in women) who may or may not have a history of previously diagnosed or treated thyroid dysfunction. Thyrotoxic storm or thyroid crisis is also a rare condition, established on the basis of a clinical diagnosis. The diagnosis is based on the pres‑ ence of severe hyperthyroidism accompanied by elements of systemic decompensation. Considering that mortality is high without aggressive treatment, therapy must be initiated as early as possible in a critical care setting.
    [Show full text]
  • Thyroid Emergencies
    The Art and Science of Infusion Nursing Angela M. Leung , MD, MSc Thyroid Emergencies cal manifestations, diagnostic methods, and treatments of ABSTRACT hypothyroidism and hyperthyroidism, both in the Myxedema coma and thyroid storm are thyroid nonacute and life-threatening forms of these diseases. emergencies associated with increased mortality. Prompt recognition of these states—which repre- sent the severe, life-threatening conditions of THYROID HORMONE PRODUCTION AND METABOLISM extremely reduced or elevated circulating thyroid hormone concentrations, respectively—is neces- sary to initiate treatment. Management of myxe- The normal physiology of the hypothalamic-pituitary- dema coma and thyroid storm requires both med- thyroid axis involves the production of T4 and T3 by the thyroid gland, a process that is regulated by thyroid- ical and supportive therapies and should be treated stimulating hormone (TSH) secreted by the pituitary, in an intensive care unit setting. which is, in turn, regulated by thyrotropin-releasing hor- Key words: hypothyroidism , hyperthyroidism , mone (TRH) secreted by the hypothalamus. Both serum ICU , myxedema coma , thyroid emergencies , T4 and T3 concentrations act as negative feedback regu- thyroid storm lators of TSH and TRH secretion, but can be altered by environmental conditions—including food availability he thyroid is a 15- to 20-gram gland located and temperature—and disease states, such as infection. 1 in the anterior neck. It is responsible for the Thyroid hormone synthesis is achieved first through production of the thyroid hormones T4 (thy- active transport of circulating iodide, which is taken in roxine) and T3 (triiodothyronine). Various from the diet, by the sodium/iodide symporter located at factors can affect thyroid hormone synthesis, the basolateral membrane of the thyroid follicular cell.
    [Show full text]
  • 15.Thyroid Disorders.Pdf
    Thyroid disorders Objectives : 1. Thyroid anatomy and physiology 2. Action of thyroid hormones 3. Thyroid function 4. Thyroid disorders: a. Goiter b. Hyperthyroidism c. Hypothyroidism Done by : Team leader: Salem Al-Ammari Team members: - Mohammed Alswoaiegh - Abdullah Alzaid - Saif almeshari - Majd Albarrak Revised by : Aseel Badukhon Resources : Doctor’s slides + Team 436 Lecturer: Prof. Assim Alfadda & Dr. Aishah Ekhzaimy Same as 436 slides: Yes Step up Important Notes Golden Notes Extra Book Thyroid gland ● Thyroid gland is made up of follicles ● Has 2 lobes and connected by the isthmus ● Weigh 20 g, more volume in men, increase with age and bodyweight and decrease with iodine intake ● Located in front of larynx Thyroid hormone ● Somatic development in adults ● Brain development in infants ● Fetal thyroid functions at 10-12 weeks of gestaion ● Maternal T4 reaches the fetus during development, if mother has hypothyroidism------------ preterm delivery, miscarriage, cognitive impairment of infant ● Main action of thyroid hormones by T3 : 80 % from peripheral conversion and 20 % produced by the thyroid itself. Follicular cells of the thyroid is the main site of hormones synthesis ● Mainly T4 and small amount of T3 ● Iodine is needed to produce thyroid hormones ● Average adult requirement of iodine is 150 mcg a day, 220 mcg for pregnants, 290 mcg for lactating ● Source of iodine: dairy and seafood products Stored in the thyroglobulin in follicular cells of Thyroid hormones synthesis the thyroid gland ● 99.9 % of T4 and T3 are bound to
    [Show full text]
  • A Case of Myxedema Coma Confounded by Dementia and Hypokalemia
    Case Report J Endocrinol Metab. 2019;9(3):71-76 A Case of Myxedema Coma Confounded by Dementia and Hypokalemia Jake Namjik Choa, b, d, Stephen Averaa, b, Kenneth Iyamua, c Abstract to decreased mental status, hypothermia, and other metabolic imbalances [1]. A common misconception is that a patient The hallmarks of myxedema coma are decreased mental status and must be comatose to be diagnosed with myxedema coma. hypothermia; but hypotension, bradycardia, hyponatremia, hypogly- Myxedema refers to the swelling of the skin and soft tissue cemia, and hypoventilation may also be present. This case involves a that occurs in patients who are hypothyroid. Myxedema coma 74-year-old female, with arthritis and dementia, who presented with occurs in the setting of decompensated hypothyroidism usu- weakness and failure to thrive. Physical exam was significant for ally precipitated by some factor such as infection [1]. The altered level of consciousness, lethargy, pretibial pitting edema and hallmark of myxedema coma is a deterioration of the patient’s hypotension. Since friends and family were absent, history was ob- mental status [1]. Although myxedema coma is exceedingly tained per chart review. Initial labs showed severe hypokalemia of 2.0 rare with about 200 cases reported between 1953 and 1996 [1], mmol/L and associated changes of prolonged QT interval and T wave and an incidence of about 0.22 million per year, more common flattening on electrocardiogram (ECG). The family later revealed ad- in women and the elderly [2], myxedema coma is a medical ditional history of thyroidectomy and clarification that the patient had emergency.
    [Show full text]
  • ATA/AACE Guidelines
    ATA/AACE Guidelines CLINICAL PRACTICE GUIDELINES FOR HYPOTHYROIDISM IN ADULTS: COSPONSORED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN THYROID ASSOCIATION Jeffrey R. Garber, MD, FACP, FACE1,2*; Rhoda H. Cobin, MD, FACP, MACE3; Hossein Gharib, MD, MACP, MACE4; James V. Hennessey, MD, FACP2; Irwin Klein, MD, FACP5; Jeffrey I. Mechanick, MD, FACP, FACE, FACN6; Rachel Pessah-Pollack, MD6,7; Peter A. Singer, MD, FACE8; Kenneth A. Woeber, MD, FRCPE9 for the American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically developed statements to assist health-care professionals in medical decision making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances. 988 989 CLINICAL PRACTICE GUIDELINES FOR HYPOTHYROIDISM IN ADULTS: COSPONSORED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN THYROID ASSOCIATION Jeffrey R. Garber, MD, FACP, FACE1,2*; Rhoda H. Cobin, MD, FACP, MACE3; Hossein Gharib, MD, MACP, MACE4; James V. Hennessey, MD, FACP2; Irwin Klein, MD, FACP5; Jeffrey I. Mechanick, MD, FACP, FACE, FACN6; Rachel Pessah-Pollack, MD6,7; Peter A.
    [Show full text]
  • Hypothyroidism-Associated Hyponatremia: MANAGEMENT OFENDOCRINEDISEASE DOI: 10.1530/EJE-16-0493 Review
    176:1 G Liamis and others Hypothyroidism and 176:1 R15–R20 Review hyponatremia MANAGEMENT OF ENDOCRINE DISEASE Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment G Liamis, T D Filippatos, A Liontos and M S Elisaf Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece Correspondence should be addressed to T D Filippatos Email [email protected] Abstract Background: Patients with moderate to severe hypothyroidism and mainly patients with myxedema may exhibit reduced sodium levels (<135 mmol/L). Summary: The aim of this short review is the presentation of the mechanisms of hyponatremia and of the available data regarding its implications and treatment in patients with hypothyroidism. Hypothyroidism is one of the causes of hyponatremia, thus thyroid-stimulating hormone determination is mandatory during the evaluation of patients with reduced serum sodium levels. The main mechanism for the development of hyponatremia in patients with chronic hypothyroidism is the decreased capacity of free water excretion due to elevated antidiuretic hormone levels, which are mainly attributed to the hypothyroidism-induced decrease in cardiac output. However, recent data suggest that the hypothyroidism-induced hyponatremia is rather rare and probably occurs only in severe hypothyroidism and myxedema. Other possible causes and superimposed factors of hyponatremia (e.g. drugs, infections, adrenal insufficiency) should be considered in patients with mild/moderate hypothyroidism. Treatment of hypothyroidism and fluid restriction are usually adequate for the management of mild hyponatremia in patients with hypothyroidism. Patients with possible European Journal European of Endocrinology hyponatremic encephalopathy should be urgently treated according to current guidelines. Conclusions: Severe hypothyroidism may be the cause of hyponatremia.
    [Show full text]
  • A Case of Myxedema Coma Presenting As a Brain Stem Infarct in a 74-Year-Old Korean Woman
    CASE REPORT Emergency & Critical Care Medicine DOI: 10.3346/jkms.2010.25.9.1394 • J Korean Med Sci 2010; 25: 1394-1397 A Case of Myxedema Coma Presenting as a Brain Stem Infarct in a 74-Year-Old Korean Woman Ji Yun Ahn1, Hyuk-Sool Kwon1, Myxedema coma is the extreme form of untreated hypothyroidism. In reality, few patients Hee Chol Ahn1, and You Dong Sohn1,2 present comatose with severe myxedema. We describe a patient with myxedema coma which was initially misdiagnosed as a brain stem infarct. She presented to the hospital with Department of Emergency Medicine1, College of Medicine, Hallym University, Anyang; Department alteration of the mental status, generalized edema, hypothermia, hypoventilation, and of Emergency Medicine2, College of Medicine, hypotension. Initially her brain stem reflexes were absent. After respiratory and circulatory Kangwon National University, Chuncheon, Korea support, her neurologic status was not improved soon. The diagnosis of myxedema coma was often missed or delayed due to various clinical findings and concomitant medical Received: 1 September 2009 Accepted: 21 December 2009 condition and precipitating factors. It is more difficult to diagnose when a patient has no medical history of hypothyroidism. A high index of clinical suspicion can make a timely Address for Correspondence: diagnosis and initiate appropriate treatment. We report this case to alert clinicians You Dong Sohn, M.D. considering diagnosis of myxedema coma in patients with severe decompensated Department of Emergency Medicine, College of Medicine, Hallym University, 170 Gwanpyong-ro, Dongan-gu, Anyang metabolic state including mental change. 431-070, Korea Tel: +82.31-380-4139, Fax: +82.31-380-4131 Email: [email protected] Key Words: Myxedema Coma; Hypothyroidism; Stroke INTRODUCTION According to the records of the local general hospital, the pa- tient had an impending respiratory arrest and comatose mental Myxedema coma represents an extreme form of hypothyroid- status.
    [Show full text]
  • Myxedema Coma: a New Look Into an Old Crisis
    SAGE-Hindawi Access to Research Journal of Thyroid Research Volume 2011, Article ID 493462, 7 pages doi:10.4061/2011/493462 Review Article Myxedema Coma: A New Look into an Old Crisis Vivek Mathew, Raiz Ahmad Misgar, Sujoy Ghosh, Pradip Mukhopadhyay, Pradip Roychowdhury, Kaushik Pandit, Satinath Mukhopadhyay, and Subhankar Chowdhury Institute of Post-Graduate Medical Education & Research, Calcutta 700020, India Correspondence should be addressed to Sujoy Ghosh, drsujoyghosh@rediffmail.com Received 1 March 2011; Accepted 12 May 2011 Academic Editor: Masanobu Yamada Copyright © 2011 Vivek Mathew et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Myxedema crisis is a severe life threatening form of decompensated hypothyroidism which is associated with a high mortality rate. Infections and discontinuation of thyroid supplements are the major precipitating factors while hypothermia may not play a major role in tropical countries. Low intracellular T3 leads to cardiogenic shock, respiratory depression, hypothermia and coma. Patients are identified on the basis of a low index of suspicion with a careful history and examination focused on features of hypothyroidism and precipitating factors. Arrythmias and coagulation disorders are increasingly being identified in myxedema crisis. Thyroid replacement should be initiated as early as possible with careful attention to hypotension, fluid replacement and steroid replacement in an intensive care facility. Studies have shown that replacement of thyroid hormone through ryles tube with a loading dose and maintenance therapy is as efficacious as intravenous therapy. In many countries T3 is not available and oral therapy with T4 can be used effectively without major significant difference in outcomes.
    [Show full text]
  • Myxedema Coma in a Hypothermic, Obtunded Patient with Post-Renal Acute Kidney Injury and Bacteremia in the Intensive Care Unit
    Case Study Myxedema Coma in a Hypothermic, Obtunded Patient with Post-renal Acute Kidney Injury and Bacteremia in the Intensive Care Unit Hernan Franco Lopez, MD; Sameer Sharif, MD; John Centofanti, MD About the Authors: Hernan Franco Lopez is PGY2 Internal Medicine Resident, Department of Medicine Internal Medicine Program - Department of Medicine at McMaster University Sameer Sharif is PGY 5 Emergency Medicine, a Fellow - Critical Care Medicine, and an Education Scholar with the Clinician Educator Program, Division of Emergency Medicine - Department of Medicine at McMaster University John Centofanti is an Anesthesiologist - Department of Anesthesia, an Intensivist - Division of Critical Care, and an Assistant Professor at McMaster University Submitted: July 29, 2018. Accepted: August 31, 2018. Published: May 21, 2019. DOI: 10.22374/cjgim.v14i2.304 Abstract We present a case of a hypothermic, unconscious patient transferred to our Intensive Care Unit with sepsis requiring mechanical ventilation. The absence of any known past medical history as well as concurrent obstructive uropathy and bacteremia made initial diagnosis challenging. He was eventually found to be in myxedema coma in light of evolving signs and laboratory investigations. This case emphasizes the need to consider myxedema coma in the differential diagnosis of profound hypothermia, especially when other clinical signs and symptoms may obscure its initial diagnosis, and lead clinicians to focus on the triggering event in isolation rather than concurrently managing hypothyroidism. This case highlights a challenging presentation of an uncommon, but life-threatening condition. We discuss the signs and symptoms present in the hypothyroid patient with myxedema coma; emphasize the pathophysiology of myxedema coma as well as the evidence-based acute management of this condition.
    [Show full text]
  • A Fatal Case of Myxedema Coma Department of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Marrakech, Marrakech, Morocco
    vv Clinical Group International Journal of Clinical Endocrinology and Metabolism DOI: http://dx.doi.org/10.17352/ijcem ISSN: 2640-7582 CC By Fatima Zahra El Bouazzaoui*, Imane Boubagura, Sana Rafi , Ghizlane El Case Report Mghari and Nawal El Ansari A fatal case of myxedema coma Department of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Marrakech, Marrakech, Morocco Received: 26 March, 2019 Abstract Accepted: 30 April, 2019 Published: 02 May, 2019 Myxedema coma is a rare clinical condition that represents severe hypothyroidism decompensation usually occurs in patient with long-standing undiagnosed hypothyroidism and is usually precipitated *Corresponding author: Fatima Zahra El Bouazzaoui, by infection and discontinuation of supplements treatment. Clinical symptoms are a mental decreased Department of Endocrinology, Diabetology and Metabolic status, hypothermia, bradycardia, hypotension, hypoglycemia and hypoventilation. Thyroid hormone Diseases, University Hospital of Marrakech, Marrakech, measurement allows the diagnosis. Protocols with rapid intravenous high doses of thyroid hormone, Morocco, E-mail: warming and mechanical ventilation may improve the prognosis. The purpose of the present article is to describe a fatal case of myxedema coma in elderly-woman occurring in the context of immunodefi ciency. Keywords: Myxedema coma; Thyroid insuffi ciency; Levothyroxine https://www.peertechz.com The patient presented with dry depilated skin, Vitiligo and generalized myxedema (Figure 1). The Glasgow Coma Score was 10 (2/3/5) .No goiter or stiffness was found after examination. Her consciousness level worsened and the patient was transferred to intensive care unit. Introduction The initial laboratory test showed a normochromic normocytic anemia without electrolyte disorders. However Myxedema coma is a very rare endocrine emergency as a because of end-stage renal failure level, patient had urea at result of a very low synthesis of thyroid hormone due to some 1,07g/l and serum creatinine at 73 mg/l.
    [Show full text]
  • Amiodarone-Induced Thyroid Dysfunction in Clinical Practice
    269-278/Art. 1.1457 16-10-2006 15:24 Pagina 269 European Review for Medical and Pharmacological Sciences 2005; 10: 269-278 Amiodarone-induced thyroid dysfunction in clinical practice S. URSELLA, A. TESTA, M. MAZZONE, N. GENTILONI SILVERI Department of Emergency Medicine, Catholic University of the Sacred Heart, Policlinico “A. Gemelli” – Rome (Italy) Abstract. – Amiodarone is a potent class III ment of ventricular arrhythmias, paroxysmal anti-arrhythmic drug used in clinical practice for supraventicular tachycardia, atrial fibrillation and the prophylaxis and treatment of many cardiac flutter1. rhythm disturbances, ranging from paroxismal As a category type-III anti-arrhythmic drug, its atrial fibrillation to life threatening ventricular tachyarrhythmias. Amiodarone often causes main mechanism of action is to block myocardial changes in thyroid function tests mainly related to potassium channels, but it also possesses some the inhibition of 5’-deiodinase activity resulting in beta-blocking properties2. a decrease in the generation of T3 from T4 with a Although highly effective in patients with ar- consequent increase in rT3 production and a de- rhythmias, its use in clinical practice is associat- crease in its clearance. In a group of amiodarone- ed with a wide array of adverse effects. With the treated patients there is overt thyroid dysfunction, cornea, the lungs, the liver, and the skin, the thy- either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). AIT is roid is one of the major organs affected. primarily related to excess iodine-induced thyroid The aim of this review is to analyse the diag- hormone synthesis in an abnormal thyroid gland nostic and therapeutic aspects of amiodarone-in- (type I AIT) or to amiodarone-related destructive duced thyroid dysfunction according to recent lit- thyroiditis (type II AIT).
    [Show full text]